Literature DB >> 1896025

Characterization of angiotensin II (AT2) binding sites in R3T3 cells.

D T Dudley1, S E Hubbell, R M Summerfelt.   

Abstract

Binding sites for angiotensin II were found, in a line of Swiss 3T3 cells (designated as R3T3 cells), that were insensitive to Dup 753 and dithiothreitol yet were sensitive to PD 123319, making them members of the AT2 class of angiotensin II binding sites. These binding sites appeared not to be coupled to guanine nucleotide-binding proteins, and affinity labeling experiments revealed a specifically labeled protein with an apparent molecular weight of about 100,000. Treatment of cells with angiotensin II revealed no perturbation of common signaling pathways, including stimulation of phosphatidylinositol turnover, effects on levels of cAMP, tyrosine kinase activity, and release of arachidonic acid. Also, angiotensin II or PD 123319 had no effect on cell growth, mitogenesis, or hypertrophy or on mitogenesis or hypertrophy stimulated by several growth factors. These results show that the AT2 binding site is quite distinct from the AT1 site in terms of molecular weight, binding properties, and coupling to second messenger systems. Although the significance of this novel angiotensin II binding site remains obscure, the identification of cell lines selectively expressing it should greatly aid in the understanding of its regulation and function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1896025

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  15 in total

Review 1.  Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Authors:  Philip Rosenstiel; Stefan Gallinat; Alexander Arlt; Thomas Unger; Jobst Sievers; Ralph Lucius
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Angiotensin AT2 receptors: cardiovascular hope or hype?

Authors:  Robert E Widdop; Emma S Jones; Ruth E Hannan; Tracey A Gaspari
Journal:  Br J Pharmacol       Date:  2003-10-06       Impact factor: 8.739

3.  Pharmacological characterization of angiotensin II AT(2) receptor subtype heterogeneity in the rat adrenal cortex and medulla.

Authors:  X Lu; K L Grove; W Zhang; R C Speth
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

5.  Characterization of AT2 receptor expression in NIH 3T3 fibroblasts.

Authors:  F M Heemskerk; S Zorad; N Xu; S J Gutkind; J M Saavedra
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

6.  Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts.

Authors:  W R Ford; A S Clanachan; C R Hiley; B I Jugdutt
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

7.  Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis.

Authors:  S Miura; S S Karnik
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

8.  Angiotensin II is a growth factor in the peri-implantation rat embryo.

Authors:  C Tebbs; M K Pratten; F Broughton Pipkin
Journal:  J Anat       Date:  1999-07       Impact factor: 2.610

9.  BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.

Authors:  K E Dickinson; R B Cohen; S Skwish; C L Delaney; R P Serafino; M A Poss; Z Gu; D E Ryono; S Moreland; J R Powell
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

10.  Angiotensin II AT2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells.

Authors:  C Nahmias; S M Cazaubon; M M Briend-Sutren; D Lazard; P Villageois; A D Strosberg
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.